logo
Share SHARE
FONT-SIZE Plus   Neg

AZZ CEO David Dingus Diagnosed With Pancreatic Cancer

AZZ Inc. (AZZ) said Monday that its President and Chief Executive Officer, David Dingus, has been recently diagnosed with cancer of the pancreas.

Dingus will begin an aggressive treatment commencing the week of March 4.

It is anticipated that during this period of treatment, all day-to-day operations will continue to be conducted by the organization currently in place, the company said and added that Dingus will continue in his role of Chief Executive Officer.

AZZ said Dingus and the senior management team will continue to work with the Board of Directors to continue to seek out all opportunities for profit enhancement, growth and expansion of the existing businesses and the successful implementation of the Aquilex SRO acquisition should the company receive the anticipated government approval to proceed.

Dingus may have a reduced work schedule during certain periods of his treatment, but he is not expected to be away for any extended periods of time, the company noted.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fast food giant McDonald's on Wednesday announced its global growth plan, targeting sales growth of 3-5% beginning in 2019. The company also highlighted its vision for new restaurants relying on technology such as self-ordering kiosks, curbside pick ups and partnerships with delivery services. At... Canadian drug-maker Valeant Pharmaceuticals International, Inc. on Tuesday reported a loss for the fourth quarter that widened from last year on a double-digit decline in revenues. However, both revenue and adjusted earnings beat analysts' estimates. Valeant also said it plans to relaunch its sexual dysfunction drug Addyi in the U.S. Electronics retailer Best Buy Co., Inc. Wednesday issued guidance for first-quarter adjusted earnings and revenues, below market estimates. Comparable sales are expected to be weak. For fiscal 2018, the company projects higher revenues and operating income. In its fourth quarter, the company posted higher profit, above market view, while revenues missed estimates with lower comparable sales.
comments powered by Disqus
Follow RTT